Markets:

Overview

News

Currencies

International

Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

11.48 +0.88 (+8.30%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

1 Small-Cap Stock with Exciting Potential and 2 We Ignore

August 07, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

August 05, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

August 01, 2025

From Pomerantz LLP

Via GlobeNewswire

Earnings Scheduled For July 29, 2025 ↗

July 29, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On NeoGenomics Through 3 Analysts ↗

July 30, 2025

Via Benzinga

NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy

July 30, 2025

From NeoGenomics, Inc.

Via Business Wire

Why NeoGenomics (NEO) Shares Are Falling Today

July 29, 2025

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 20.2% in the morning session after the company reported second-quarter results that included a significant cut to its...

Via StockStory

Topics Lawsuit

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 29, 2025

Via Benzinga

Whirlpool Posts Downbeat Earnings, Joins Harmonic, Stanley Black & Decker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 29, 2025

Via Benzinga

NeoGenomics (NASDAQ:NEO) Misses Q2 Sales Targets, Stock Drops 15.8%

July 29, 2025

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) missed Wall Street’s revenue expectations in Q2 CY2025, but sales rose 10.2% year on year to $181.3 million. The company’s full-year...

Via StockStory

NeoGenomics Reports Second Quarter 2025 Results

July 29, 2025

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics (NEO) Reports Q2: Everything You Need To Know Ahead Of Earnings

July 27, 2025

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting earnings this Tuesday before market hours. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

3 of Wall Street’s Favorite Stocks We’re Skeptical Of

July 25, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know

July 18, 2025

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like...

Via StockStory

Topics Lawsuit World Trade

3 Stocks Under $10 We’re Skeptical Of

July 18, 2025

Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as...

Via StockStory

Q1 Earnings Highlights: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Testing & Diagnostics Services Stocks

July 14, 2025

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the testing & diagnostics services industry, including NeoGenomics (NASDAQ:NEO) and its peers.

Via StockStory

NeoGenomics, RadNet, Pediatrix Medical Group, Penumbra, and Neogen Shares Plummet, What You Need To Know

July 11, 2025

A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.

Via StockStory

Topics ETFs Stocks World Trade

3 Russell 2000 Stocks with Questionable Fundamentals

July 09, 2025

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Via StockStory

Topics Artificial Intelligence

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO

July 06, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO

July 01, 2025

From Pomerantz LLP

Via GlobeNewswire

NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025

July 01, 2025

From NeoGenomics, Inc.

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO

June 30, 2025

Via ACCESS Newswire

NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care

June 30, 2025

From NeoGenomics, Inc.

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO

June 26, 2025

Via ACCESS Newswire

Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out ↗

June 25, 2025

BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences.

Via Benzinga

Topics Artificial Intelligence

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO

June 25, 2025

Via ACCESS Newswire

3 Hot Trades for Insiders, But Are They Good Buys for Investors?

June 24, 2025

Insiders are buying Hudson Pacific Properties and NeoGenomics, but selling Carvana. These trends will likely continue in 2025.

Via MarketBeat

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO

June 24, 2025

Via ACCESS Newswire

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

June 24, 2025

From NeoGenomics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

NeoGenomics, Inc. - Common Stock (NQ:NEO)

All News about NeoGenomics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today